DM
ELOS

Deerfield Management’s Syneron Medical Ltd ELOS Stock Holding History

Deerfield Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,079,013
Closed -$14.9M – 140
2015
Q3 		$14.9M Buy
2,079,013
+105,068
+5% +$1.01M 0.58% 56
2015
Q2 		$21M Buy
1,973,945
+1,348,352
+216% +$15.8M 0.7% 52
2015
Q1 		$7.75M Buy
+625,593
New +$6.93M 0.25% 72
2014
Q4 		– Sell
-13,893
Closed -$139K – 148
2014
Q3 		$139K Buy
+13,893
New +$141K 0.01% 130
2014
Q2 		– Sell
-34,518
Closed -$430K – 151
2014
Q1 		$430K Buy
+34,518
New +$409K 0.02% 122

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deerfield Management's ELOS Position: Q4 2015 in Review

Deerfield Management sold out of Syneron Medical Ltd (ELOS) in Q4 2015, closing a stake of 2,079,013 shares — an estimated $14.9M sold.

Deerfield Management first reported a position in ELOS in Q1 2014 and held it in 5 quarters. The position peaked at $21M in Q2 2015. 57 funds tracked by Wall St. Rank hold ELOS as of Q4 2015.

  • Deerfield Management reported no remaining Syneron Medical Ltd position as of Q4 2015 after selling out during the quarter.
  • Deerfield Management sold 2,079,013 Syneron Medical Ltd shares in Q4 2015, an estimated $14.9M.
  • Deerfield Management first reported a position in Syneron Medical Ltd in Q1 2014 and held it in 5 quarters.
  • Deerfield Management's Syneron Medical Ltd position peaked at $21M in Q2 2015.
  • 57 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2015.

Based on Deerfield Management's 13F filing for Q4 2015, filed 16 Feb 2016.